| CLASS | DRUG/TOX | LP7790-1 |
| COMPONENT | Tobramycin | LP16294-8 |
| PROPERTY | MCnc | LP6827-2 |
| TIME_ASPCT | Pt | LP6960-1 |
| SYSTEM | Body fld | LP7238-1 |
| SCALE_TYP | Qn | LP7753-9 |
| parent | Tobramycin | Body fluid | Drug toxicology | LP389049-0 |
| CLASSTYPE | Laboratory class | |
| ORDER_OBS | Both | |
| EXAMPLE_UNITS | ug/mL | |
| EXAMPLE_UCUM_UNITS | ug/mL | |
| UNITSREQUIRED | Y |
| LONG_COMMON_NAME | en-US | Tobramycin [Mass/volume] in Body fluid |
| LONG_COMMON_NAME | en-US | Tobramycin [Mass/volume] in Body fluid |
| SHORTNAME | en-US | Tobramycin Fld-mCnc |
| ConsumerName | en-US | Tobramycin, Body fluid |
| SHORTNAME | es-AR | tobramicina:concentración de masa:punto en el tiempo:líquido corporal, no especificado:cuantitativo: |
| SHORTNAME | pt-BR | Tobramycin Fld-mCnc |
| LONG_COMMON_NAME | fr-FR | Tobramycine [Masse/Volume] Liquide biologique ; Numérique |
| LONG_COMMON_NAME | nl-NL | Tobramycine [massa/volume] in lichaamsvocht |
| LONG_COMMON_NAME | es-MX | Tobramicina: Fluído corporal : Punto temporal: Concentración de masa: Cuantitativo: |
LOINC Version: 2.77
FHIR